Teva Pharmaceutical Industries Limited (TEVA)
Largest Insider Buys in Sector
TEVA Stock Price History Chart
TEVA Stock Performance
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Insider Activity of Teva Pharmaceutical Industries Limited
Over the last 12 months, insiders at Teva Pharmaceutical Industries Limited have bought $0 and sold $18.51M worth of Teva Pharmaceutical Industries Limited stock.
On average, over the past 5 years, insiders at Teva Pharmaceutical Industries Limited have bought $0 and sold $10.13M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 209,000 shares for transaction amount of $2.01M was made by BARER SOL J (director) on 2019‑06‑04.
List of Insider Buy and Sell Transactions, Teva Pharmaceutical Industries Limited
| 2024-06-18 | Sale | MIGNONE ROBERTO | director | 519,000 0.045% | $17.03 | $8.84M | -1.65% | |
| 2024-05-16 | Sale | Weiss Amir | Chief Accounting Officer | 12,635 0.0011% | $16.65 | $210,377 | +3.47% | |
| 2024-05-15 | Sale | Weiss Amir | Chief Accounting Officer | 15,500 0.0014% | $16.80 | $260,417 | +0.42% | |
| 2024-05-13 | Sale | Conway Vikki L | See "Remarks" | 15,219 0.0013% | $16.74 | $254,807 | -0.18% | |
| 2024-03-06 | Sale | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 77,550 0.0069% | $13.52 | $1.05M | +4.36% | |
| 2024-03-05 | Sale | Sabag Mark | EVP, International Markets | 100,000 0.0089% | $13.52 | $1.35M | +4.29% | |
| 2024-03-05 | Sale | Daniell Richard | Exec. VP, European Commercial | 48,629 0.0043% | $13.52 | $657,240 | +4.29% | |
| 2024-03-05 | Sale | Conway Vikki L | See "Remarks" | 1,427 0.0001% | $13.52 | $19,286 | +4.29% | |
| 2024-03-04 | Sale | Francis Richard D | President and CEO | 31,061 0.0028% | $13.34 | $414,270 | +4.95% | |
| 2024-03-04 | Sale | Daniell Richard | Exec. VP, European Commercial | 33,512 0.003% | $13.34 | $446,960 | +4.95% | |
| 2024-03-04 | Sale | Hughes Eric A | See "Remarks" | 8,045 0.0007% | $13.34 | $107,299 | +4.95% | |
| 2024-03-04 | Sale | Conway Vikki L | See "Remarks" | 3,532 0.0003% | $13.37 | $47,235 | +4.95% | |
| 2024-02-28 | Sale | Daniell Richard | Exec. VP, European Commercial | 20,599 0.0018% | $13.12 | $270,176 | +7.56% | |
| 2024-02-28 | Sale | Drape Eric | Executive VP Global Operations | 9,815 0.0009% | $13.12 | $128,734 | +7.56% | |
| 2024-02-28 | Sale | Conway Vikki L | See "Remarks" | 1,366 0.0001% | $13.12 | $17,916 | +7.56% | |
| 2024-02-16 | Sale | Drape Eric | Executive VP Global Operations | 173,261 0.0155% | $13.05 | $2.26M | +7.68% | |
| 2024-02-15 | Sale | Francis Richard D | President and CEO | 74,530 0.0066% | $13.15 | $980,174 | +5.98% | |
| 2024-02-01 | Sale | Weiss Amir | Chief Accounting Officer | 31,766 0.003% | $12.37 | $392,955 | +11.64% | |
| 2023-08-07 | Sale | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 35,125 0.0032% | $9.73 | $341,889 | +18.56% | |
| 2023-08-04 | Sale | Weiss Amir | Chief Accounting Officer | 1,981.41 0.0002% | $9.92 | $19,658 | +16.70% |
Insider Historical Profitability
| MIGNONE ROBERTO | director | 981000 0.1338% | $16.25 | 2 | 1 | +9.88% |
| Drape Eric | Executive VP Global Operations | 9701 0.0155% | $16.25 | 0 | 17 | |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 203691 0.0088% | $16.25 | 0 | 3 | |
| Francis Richard D | President and CEO | 123295 0.0078% | $16.25 | 0 | 2 | |
| Daniell Richard | Exec. VP, European Commercial | 69770 0.0062% | $16.25 | 0 | 27 | |
| Sabag Mark | See "Remarks" below | 382590 0.0018% | $16.25 | 0 | 5 | |
| Weiss Amir | Chief Accounting Officer | 5179 0.001% | $16.25 | 0 | 4 | |
| Conway Vikki L | See "Remarks" | 0 0.0003% | $16.25 | 0 | 4 | |
| Hughes Eric A | See "Remarks" | 16855 0% | $16.25 | 0 | 2 | |
| BARER SOL J | director | 220442 0.0197% | $16.25 | 2 | 0 | +0.5% |
| Dethlefs Sven | EVP, North America Commercial | 165381 0.0148% | $16.25 | 1 | 17 | <0.0001% |
| Crane Rosemary A | director | 33509 0.003% | $16.25 | 0 | 1 | |
| de Notaristefani Carlo | Executive VP Global Operations | 33589 0.003% | $16.25 | 0 | 4 | |
| McClellan Michael James | EVP, Chief Financial Officer | 15898 0.0014% | $16.25 | 0 | 6 | |
| O'Grady Brendan P. | EVP, North America Commercial | 14868 0.0013% | $16.25 | 0 | 17 | |
| Shani Eli | EVP,Global Marketing&Portfolio | 9091 0.0008% | $16.25 | 0 | 1 | |
| Codner Iris Beck | EVP Global Brand&Communication | 8290 0.0007% | $16.25 | 0 | 1 | |
| Stark David Matthew | Exec. VP Chief Legal Officer | 2974 0.0003% | $16.25 | 0 | 20 | |
| Fridriksdottir Hafrun | Executive VP, Global R&D | 1387 0.0001% | $16.25 | 0 | 22 | |
| Nazzi Gianfranco | EVP, International Markets | 0 0% | $16.25 | 0 | 14 | |
| Griffin Deborah A | Chief Accounting Officer | 0 0% | $16.25 | 0 | 12 |
Institutional Investor Ownership
| BlackRock | $616.67M | 3.86 | 43.7M | +4.89% | +$28.78M | 0.01 | |
| ION Asset Management | $544.34M | 3.41 | 38.58M | -4.34% | -$24.68M | 39.63 | |
| Phoenix Holdings Ltd | $488.08M | 3.05 | 34.58M | +0.58% | +$2.8M | 6.78 | |
| Migdal Insurance Financial Holdings Ltd | $421.29M | 2.64 | 29.86M | +3.24% | +$13.24M | 6.89 | |
| Clal Insurance Enterprises Holdings Ltd | $406.06M | 2.54 | 28.79M | -12.22% | -$56.55M | 4.71 | |
| Menora Mivtachim Holdings Ltd | $396.9M | 2.48 | 28.13M | 0% | +$0 | 3.08 | |
| Slate Path Capital LP | $379.51M | 2.38 | 26.9M | +2.54% | +$9.38M | 7.56 | |
| EXOR INVESTMENTS (UK) LLP | $372.85M | 2.33 | 26.42M | -23.31% | -$113.35M | 15.68 | |
| Fidelity Investments | $299.82M | 1.88 | 21.25M | +679.65% | +$261.36M | 0.02 | |
| Helm Capital Management LLC | $249.32M | 1.56 | 17.67M | -3.06% | -$7.86M | 7.37 | |
| State Street | $228.91M | 1.43 | 16.22M | -0.87% | -$2.01M | 0.01 | |
| Millennium Management LLC | $151.67M | 0.95 | 10.75M | -28.68% | -$60.98M | 0.11 | |
| AustralianSuper | $140.66M | 0.89 | 10.11M | +11.87% | +$14.93M | 0.82 | |
| Geode Capital Management | $113.9M | 0.72 | 8.1M | +4.16% | +$4.55M | 0.01 | |
| Renaissance Technologies | $108.61M | 0.68 | 7.7M | +41.61% | +$31.91M | 0.17 | |
| Glenview Capital Management | $105.84M | 0.66 | 7.5M | +367.48% | +$83.2M | 2.06 | |
| Sound Shore Management Inc Ct | $105.75M | 0.66 | 7.49M | -15.97% | -$20.1M | 3.31 | |
| Alyeska Investment Group L P | $89.54M | 0.56 | 6.35M | +16.24% | +$12.51M | 0.56 | |
| Eversept Partners LP | $85.02M | 0.53 | 6.03M | -2.1% | -$1.82M | 6.4 | |
| Morgan Stanley | $76.56M | 0.48 | 5.43M | -34.04% | -$39.5M | 0.01 | |
| Legal & General | $74.41M | 0.47 | 5.27M | -1.44% | -$1.09M | 0.02 | |
| PointState Capital LP | $72.03M | 0.45 | 5.1M | New | +$72.03M | 2.18 | |
| Citadel Advisors LLC | $72.1M | 0.45 | 5.11M | -55.96% | -$91.62M | 0.05 | |
| Parsifal Capital Management Lp | $71.23M | 0.45 | 5.05M | New | +$71.23M | 4.92 | |
| Holocene Advisors, LP | $70.02M | 0.44 | 4.96M | -5.62% | -$4.17M | 0.26 | |
| Maple Rock Capital Partners Inc | $61.57M | 0.39 | 4.36M | +68.25% | +$24.97M | 3.9 | |
| Marshall Wace | $59.48M | 0.37 | 4.22M | +104.38% | +$30.38M | 0.08 | |
| Bank of America | $58.72M | 0.37 | 4.16M | +75.61% | +$25.28M | 0.01 | |
| Neuberger Berman | $56.86M | 0.36 | 4.03M | +15,695.99% | +$56.5M | 0.05 | |
| BB&T | $51.23M | 0.32 | 3.63M | +2,609.08% | +$49.34M | 0.08 | |
| Citigroup | $51.05M | 0.32 | 3.62M | +875.98% | +$45.82M | 0.04 | |
| Goldman Sachs | $50M | 0.31 | 3.54M | -6.87% | -$3.69M | 0.01 | |
| Northern Trust | $49.91M | 0.31 | 3.54M | -1.4% | -$706,036.19 | 0.01 | |
| Soleus Capital Management, L.P. | $49.19M | 0.31 | 3.49M | -37.34% | -$29.32M | 0.47 | |
| Swiss National Bank | $47.2M | 0.3 | 3.34M | -4.48% | -$2.21M | 0.03 | |
| Capital International Investors | $44.95M | 0.28 | 3.19M | -68.07% | -$95.83M | 0.01 | |
| Balyasny Asset Management Llc | $44.05M | 0.28 | 3.12M | New | +$44.05M | 0.12 | |
| JPMorgan Chase | $42.44M | 0.27 | 3.01M | +42.38% | +$12.63M | <0.01 | |
| Iron Triangle Partners LP | $39.08M | 0.25 | 2.77M | +113.07% | +$20.74M | 4.04 | |
| Mangrove Partners | $38.97M | 0.24 | 2.76M | New | +$38.97M | 0.39 | |
| Nuveen | $37.19M | 0.23 | 2.64M | +58.75% | +$13.77M | 0.01 | |
| Grantham Mayo Van Otterloo & Co LLC | $34.33M | 0.22 | 2.43M | -25.82% | -$11.95M | 0.13 | |
| Fil Ltd | $33.82M | 0.21 | 2.4M | +2.85% | +$938,145.68 | 0.03 | |
| Ubs Asset Management Americas Inc | $31.37M | 0.2 | 2.22M | -1.75% | -$557,147.46 | 0.01 | |
| Tri Locum Partners Lp | $31.27M | 0.2 | 2.22M | +23.51% | +$5.95M | 11.03 | |
| UBS | $31.02M | 0.19 | 2.2M | +143.58% | +$18.28M | 0.01 | |
| Sumitomo Mitsui Trust Holdings | $30.47M | 0.19 | 2.16M | +1.3% | +$391,030.43 | 0.02 | |
| Deutsche Bank | $30.23M | 0.19 | 2.14M | +6.72% | +$1.9M | 0.01 | |
| D. E. Shaw & Co. | $27.08M | 0.17 | 1.92M | +26.7% | +$5.7M | 0.04 | |
| BECK MACK + OLIVER | $26.72M | 0.17 | 1.89M | -22.15% | -$7.6M | 0.54 |